Jakob (“Jaap”) Kampinga MD
The Supervisory Board is chaired by Jaap Kampinga, a medical doctor, academic scientist, and serial biotech entrepreneur. Since 2003, Jaap Kampinga is a partner and Managing Director of Oakes, Lyman & Co. Ltd (London, UK), a small, FSA-regulated company that takes on the role of a serial entrepreneur by originating, building, organizing finance and attracting experienced management for European medical businesses that have...
Theo Buunen PhD
Theo, who recently retired in 2012 from his position as CEO of Sanquin in Amsterdam. Sanquin, an organisation with 3,000 employees, collects blood in the Netherlands, and produces and distributes blood products and plasma products in the Netherlands and abroad. Sanquin is the result of the merger in 1997 of 22 independent blood banks and the CLB, a national plasma fractionator.
Henrik Luessen PhD
Henrik Luessen started his own business advisory firm Tytonis BV (www.tytonis.com) in 2006 after leaving his previous position as CBO of OctoPlus (www.octoplus.nl) prior to its public offering. During these seven years of his employment he commercially developed the company from a group of 12 employees with a core expertise in pharmaceutical development services of biopharmaceutical compounds...
Paul Lelieveld Ir
Paul Lelieveld combines deep knowledge of the food, water, and life science industry with significant experience in investment and business development. His passion clearly lies in the field of innovation and building businesses. Here, he can create a lot of value by combining his strong people skills with analytical and strategic capabilities. In 2012, Paul started his own advisory firm, HalcyonBlue.